ArticleClinical lymphoma, myeloma & leukemia2011

Pilot study of bortezomib for patients with imatinib-refractory chronic myeloid leukemia in chronic or accelerated phase.

Fabio P S Santos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.